Fertility treatment benefits

(a) In general Section 8904 of title 5, United States Code, is amended— (1) in subsection (a)— (A) in paragraph (1), by adding at the end the following new subparagraph: (G) Fertility treatment benefits.; and (B) in paragraph (2)— (i) by redesignating subparagraph (F) as subparagraph (G); and (ii) by inserting after subparagraph (E) the following new subparagraph: (F) Fertility treatment benefits.; and (2) by adding at the end the following new subsection: (c) In this section, the term fertility treatment means— (1) preservation of human oocytes, sperm, or embryos for later reproductive use; (2) artificial insemination, including intravaginal insemination, intracervical insemination, and intrauterine insemination; (3) assisted reproductive technology, including in vitro fertilization and other treatments or procedures in which reproductive genetic material, such as oocytes, sperm, fertilized eggs, and embryos, are handled, when clinically appropriate; (4) genetic testing of embryos; (5) medications prescribed or obtained over-the-counter, as indicated for fertility; (6) gamete donation; and (7) such other information, referrals, treatments, procedures, medications, laboratory services, technologies, and services relating to fertility as the Director of the Office of Personnel Management, in coordination with the Secretary of Health and Human Services, determines appropriate.. (b) Effective date The amendments made by this Act shall take effect on the date that is 1 year after the date of the enactment of this Act.